Oncology
Erica Mayer, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School; Director, Breast Cancer Clinical Research, Dana-Farber Breast Oncology Program
Erica L. Mayer, MD, MPH, is a nationally recognized medical oncologist specializing in the care of patients with all stages of breast cancer at the Dana-Farber Cancer Institute in Boston, Massachusetts. She serves as the director of Breast Cancer Clinical Research within the Dana-Farber Breast Oncology Program, leading national and global clinical trials to address key questions in breast oncology. Her research emphasizes novel agents for breast cancer treatment, with a particular focus on strat
25+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine)
- Internal Medicine (American Board of Internal Medicine)
Education & Training
- Harvard School of Public Health — MPH
- Harvard Medical School — MD
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute — Fellowship, Hematology and Medical Oncology, 2003 - 2006
- Mass General Brigham/Brigham and Women's Hospital — Residency, Internal Medicine, 2000 - 2003
Peer Recognition
- CMS — Meaningful Use Stage 2 Certification
2013-2015, 2017 (4 years)
- Castle Connolly — Top Doctor
2022-2026 (5 years)
Recognition & Leadership
Awards & Honors
- 2023 Canellos Award for Excellence in Clinical Investigation and Patient Care
- 2024 Dana-Farber Clinical Innovation Award
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
Languages
English
Experience
25+ years in practice